BURRELL INTERNATIONAL GROUP LLC

Lobbying for OXYGENIUM INC. · High-flow delivery medical oxygen

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate · posted Apr 17, 2026

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Funding for portable oxygen generation systems; FY27 Defense Appropriations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.